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Interstitial cells of Cajal (ICCs) are pacemakers in the gastrointestinal (GI) tract that regulate 
intestinal motility through spontaneous electrical slow waves. ICCs have been shown to express the 
receptor tyrosine kinase c-Kit, which is the receptor for stem cell factor. While recent studies have found 
that reduction of c-Kit expression in ICC induces abnormal contractile patterns in the GI tract in diabetic 
mouse models, further investigation are still needed in order to address underlying mechanisms. 
MicroRNAs (miRNAs) are a new class of transcriptional regulators that are involved in nearly all 
developmental and pathological processes in animals. The specific goals of this research project were: (1) 
to identify miRNA profiles in ICC from jejunum and colon smooth muscle through genome-wide miRNA 
sequencing (miRNA-seq) technology in both non-diabetic and diabetic mouse models, and (2) to 
characterize gene functions encoded in these miRNA circuits using microRNA target validation and 
pathway analysis programs. Genome-wide miRNA-seq identified 11,381,897 to 19,938,908 raw reads in 
total for non-diabetic and diabetic ICC isolated from jejunum and colon smooth muscle. Interestingly, 
miR-10b-5p expressed the most change in diabetic ICC through its significant downregulation. Target 
genes for miR-10b-5p were identified using the five databases found in miRbase which include: DIANA-
MICROT, MICRORNA.ORG, MIRDB, RNA22-MMU, and TARGETSCAN-VERT. A network was 
then graphically depicted in order to show gene relationships between diabetes mellitus, miR-10b and its 
gene targets, and c-Kit through the Ingenuity Pathway Analysis (IPA) program. From these two analyses, 
it was found that Bcl2l11 and Ncor2 were the most optimal target genes for miR-10b. Immunoblotting 
analysis showed that NCOR2 was clearly upregulated in diabetic smooth muscle, while BCL2L11 
showed no expression in either diabetic or non-diabetic conditions. Finding novel molecular mechanisms 
relating to diabetic miRNAs could provide a better understanding of the disease, and may have significant 
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Diabetes mellitus is a medical disease that affects millions of people worldwide. It 
disables the body from producing sufficient amounts of insulin in order to regulate glucose 
levels. Diabetes takes on two primary forms: Type I diabetes occurs because of insufficient 
amounts of insulin production in pancreatic β-cells. Type II diabetes occurs because of insulin 
resistance that results in inadequate usage of insulin in the body (Che, Lan, Roukos, and Cho, 
2014).  By 2030, around 450 million individuals are expected to have diabetes with an estimated 
global economic cost of roughly $500 billion per year (Wild, Roglic, Green, Sicree, and King, 
2004). 
Individuals with diabetes usually suffer from a variety of gastrointestinal (GI) disorders 
(Verne and Sninsky, 1998). These various complications could range from abdominal pain to 
dysphagia and many other symptoms (Bytzer et al. 2001; Feldman and Schiller, 1983). The GI 
tract is affected in the presence of diabetes in that its motility becomes irregular (Rothstein, 
1990). Other abnormalities in the GI, such as poor glucose regulation and motor dysfunction 
have been demonstrated in the presence of this disorder (Jun, 2011). 
Interstitial cells of Cajal (ICCs) are pacemaker cells that play a very important role in the 
motility of the GI tract (Al-Sajee and Huizinga, 2012). ICCs regulate this motility through 
spontaneous electrical slow waves (Ward, Burns, Torihashi, and Sanders, 1994).  Ward et al. 
(1994) have demonstrated that ICCs express the tyrosine kinase protein receptor c-Kit, which is 
the receptor for stem cell factor. Krihnamurthy et al. (2007) have also shown that c-Kit plays an 
important role in the regulation of glucose metabolism.  
Previous data from Dr. Ro’s laboratory showed that ICC and c-Kit were significantly lost 
in diabetic conditions (Figs 1 and 2).  Other studies have also indicated that a decrease in ICC 
! 2!
expression can be seen in both diabetic mice and human models resulting from diminishing c-Kit 










Figure 2. Preliminary data showing loss of ICC and c-KIT in the jejunum of diabetic mice 




MicroRNAs (miRNAs) are small noncoding RNA molecules of 21-25 nucleotides that 
are involved in gene regulation (Liu et al., 2014). They can bind to the 3’ untranslated region 
(UTR) of messenger RNAs (mRNAs), resulting in the inhibition of translation (Bartel, 2014). 
MiRNAs play pivotal roles in nearly all developmental and pathological processes in animals 
including: apoptosis, differentiation, and cell proliferation (Bartel 2014;Sempere et al., 2004; 
Ambros, 2004). Changes in miRNAs are linked to the emergence of numerous diseases, such as 
diabetes (Liu et al., 2014). With this, defective ICCs caused by miRNA regulation are likely to 
be involved in the occurrence of diabetes.  
The specific goals of this research project were: (1) to identify miRNA profiles in ICC 
from jejunum and colon smooth muscle through genome-wide miRNA sequencing (miRNA-seq) 
technology in both non-diabetic and diabetic mouse models and (2) to characterize gene 
functions encoded in these miRNA circuits using microRNA target validation and pathway 
analysis programs. This is important as there is a lack of research relating to defective ICC 
pathways. Finding novel pathways relating to miRNAs and diabetes could provide a better 
understanding of the disease and may have significant therapeutic implications, especially in the 
prevention of ICC damage in patients with GI complications. 
 
Literature Review 
This research project draws insights from comparing the roles of the regulation of 
miRNAs in the emergence of diabetes. For instance, Liu et al. (2014) have observed circulating 
levels of miR-126 in patients with Type II diabetes, as population-based data have revealed that 
miR-126 and Type II diabetes strongly interacted with each other. Similarly, Rong et al. (2013) 
have observed circulating levels of miR-146a in patients that have been recently diagnosed with 
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Type II diabetes. From past research, they have shown that miRNA-146a seemed to be involved 
in the expression of heme oxygenase-1 (HO-1), an enzyme that increases in new type 2 diabetes 
patients.  
This research project differs from these two studies as Liu et al. focused more on 
miRNAs circulating in bodily fluids while Rong et al. focused more on miRNA interaction 
within endothelial cells. The focus of this study was to look for an influential miRNA in the 
dysregulation of the GI tract during diabetes. So far, miRNA GI research in diabetes is lacking, 
especially with a focus on ICC. Other studies tended to focus on the effects of compounds on the 
GI tract, rather than miRNAs themselves. For instance, Kim et al. (2011) have looked at levels of 
nitric oxide (NO) or carbachol in the long term dysfunction in the colons of diabetic mice, as NO 
is correlated with the relaxation of the smooth muscle in the GI tract (Ueno, Duenes, Zarroug, 
and Sarr, 2004). Others have also studied the role of acetylcholine in the regulation of GI 
motility (Huizinga, Change, Diamant, El-Sharkawy, 1984).  
 
Materials and Methods 
Species (Mouse) and Tissue 
 
Small RNAs from the ICCs in the jejunum and colon of 60 age-matched control (non-
diabetic) mice (labeled as ob/+) and 60 diabetic mice (labeled as ob/ob) were isolated and set for 
next-generation sequencing. The ICCs from the diabetic and control group tissues were also 
categorized and surveyed through Fluorescence-activated cell sorting (FACS). Protocols 
involving mice were handled according to procedures approved by the Institutional Animal Care 




MicroRNA sequencing analysis 
  
Raw reads from miRNA sequencing profiles that were obtained from the next-generation 
sequencing were normalized and filtered based on quality through alignment with a miRNA 
sequence database (miRbase). Comparative analysis of miRNA expression levels was done 
between the control and diabetc variants of mouse jejunum and colon ICC based on Fragments 
Per Kilobase of Exon Per Million Mapped Reads (FPKM) values. Also, A heat map macro for 
Microsoft Excel ('TSG-1.xls'!HeatMap.HeatMap) was used to complete the comparative analysis 
by converting the FPKM values on a log-scale. The log range of the heat map ranged from 0.1-5, 
covering an FPKM scope of 0 to 100,000. Bright red represents high expression of miRNAs, 
while bright green represents low expression of miRNAs. 
 
MicroRNA target predictions  
 
Target genes for the most changed miRNA were identified using the five databases found 
in miRbase (mirbase.org). These databases included DIANA-MICROT, MICRORNA.ORG, 
MIRDB, RNA22-MMU, and TARGETSCAN-VERT. From the five databases, the top 100 
genes were chosen and sorted according to gene scores. Predicted genes that matched with at 




Pathway analysis was performed on the target gene candidates using the Ingenuity 
Pathway Analysis (IPA) program based on the most changed miRNA. Parameters that were set 
required that the gene candidate must be linked to diabetes mellitus and have an interaction with 
c-Kit. Candidates that met filter criteria and had at least one published evidence were deemed as 
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the target genes. A network was graphically depicted in order to show gene relationships 
between diabetes mellitus, miR-10b and its target genes, and c-Kit.  
 
Western Blot Analysis  
 
Immunoblotting for protein expression analysis was performed based on the protocol 
described by Park et al. (2011). Of the total proteins, 20 µg were extracted from the small 
intestine or colon smooth muscle tissue lysates from the diabetic Kit+/copGFP;Lepob/ob and WT 
Kit+/copGFP mice. These were then separated on 10% SDS-polyacrylamide gels and transferred to 
Trans-Blot Transfer Medium (Pure Nitrocellulose Membrane, Bio-Rad, Hercules). The 
membranes were blocked with 5% non-fat milk and incubated with goat anti-KIT (1:1000) 
(R&D Systems), rabbit anti-SMRTe (NCOR2), (1:100) (Santa Cruz Biotechnology), rabbit anti-
Bim (BCL2L11), (1:100) (Santa Cruz Biotechnology), or rabbit anti-GAPDH antibody (1:1500) 
(Abcam). The protein–antibody complex was detected following incubation with the horseradish 
peroxidase-conjugated secondary antibodies (1:50 000) (Chemicon) using an enhanced 
chemiluminescence method (ECL Advantage, Amersham Bioscience). The protein bands were 
captured with a CCD-camera system (EC3 410 Imaging System, UVP Laboratory Products). The 
bands were also analyzed through VisionWorksLS software (Version 6.8, UVP Laboratory 
Products). The expression levels of NCOR2 and BCL2L11 were normalized to the ratio of 
NCOR2 and BCL2L11 and area density divided by GAPDH area density. For quantitative 
measurements, the values of relative expression for NCOR2 and BCL2L11 in small intestine and 






microRNA sequencing analysis 
 
     miRNA sequencing profiles of around 11 to 20 million raw reads were obtained from next-
generation sequencing for the control and diabetic variants of colon and jejunum ICC (Table 1). 
Normalization of the raw reads and the use of the ‘TSG-1.xls'!HeatMap.HeatMap macro in 
Microsoft Excel showed the miRNA expression levels in the control and diabetic variants of 
colon and jejunum ICC (Appendix). From the top 10 most expressed miRNAs, it was revealed 
that miR-10b-5p experienced the most change in expression levels in both tissue types when 
comparing diabetic and non-diabetic conditions (Fig 3). The heat map also showed that under 





Table 1. miRNA sequencing profiles of raw reads obtained from next-generation 











Sample Control Jejunum Diabetic Jejunum Control Colon Diabetic Colon 





Figure 3. From the top 10 most expressed microRNAs in control (non-diabetic) and 
diabetic colon and jejunum samples, miR-10b-5p experienced the most change in 
expression levels.  Out of the 983 miRNAs expressions sequenced (Appendix) in control 
jejunum ICC (red), diabetic jejunum ICC (blue), control colon (orange), and diabetic colon (light 
blue), miR-10b expressed the most dramatic change out of all miRNAs. The miRNA expressions 
for miR-10b under non diabetic conditions were 74,026 in the jejunum and 74,958 in the colon 
ICCs. In diabetic conditions however, expression levels dropped to 5,818 in the jejunum and 





Figure 4. mmu-miR-10b-5p showed the most reduction in diabetic ICC.  Heat map analysis 
of the top 20 most expressed miRNAs in the jejunum (A) and colon (B) ICCs showed that miR-
10b became severely downregulated in diabetic conditions. Expression levels for each miRNA 































MicroRNA target predictions and IPA analysis 
  
     Through the use of 5 microRNA databases (DIANA-MICROT, MICRORNA.ORG, MIRDB, 
RNA22-MMU, and TARGETSCAN-VERT) found in miRbase, target genes were identified for 
miR-10b-5p. Of the top 100 genes based on the gene scores for each of the 5 databases, 75 genes 
matched with at least 2 databases (Table 2). Sorting of the predicted genes showed that 10 genes 
were predicted in 4 databases, 18 were predicted in 3 databases, and 47 were predicted in 2 
databases. All these genes were used as potential candidate targets for miR-10b-5p. The 
candidate genes were imported to the Ingenuity Pathway Analysis Program (IPA) in order to 
obtain a pathway of which these genes interacted with miR-10b along with c-Kit and diabetes 
mellitus (Fig 5.). The IPA program reduced the 75 available target genes to 61, accounting for 
synonymous gene names. The IPA program also showed that BCL2L11 and NCOR2 were 
correlated with these parameters. From miRNA-sequencing and IPA analysis, we generated a 
figure for our expected model, stating that under diabetic conditions, the downregulation of miR-




















Table 2. Most commonly predicted genes relating to miR-10b-5p among five microRNA 
databases. Target genes for the most reduced miRNA (miR-10b-5p) were identified with the use 
of miRbase. To predict target genes, miRbase uses five other databases including: DIANA-
MICROT, MICRORNA.ORG, MIRDB, RNA22-MMU, and TARGETSCAN-VERT. The top 
100 genes, according to genes scores for each database were chosen. Predicted genes that match 



































Figure 5. BCL2L11 and NCOR2 network both miR-10b-5p and KIT in diabetes mellitus. 
The Ingenuity Pathway Analysis (IPA) program was used in order to find a pathway among the 




Figure 6.  Under diabetic conditions, the downregulation of miR-10b-5p upregulates 
Bcl2l11 and Ncor2, which downregulates c-Kit. This is the proposed pathway that that links 
miR-10b-5p to diabetes, based from miRNA and gene analysis under diabetic conditions. 
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Western Blot Analysis 
 
  
To verify our expected model’s prediction based on  miRNA-sequencing and IPA 
analysis, we conducted Western blots from jejunum and colon tissue samples in order to see if 
BCL2L11 and NCOR2 will indeed be highly expressed in diabetic conditions. Interestingly, 
NCOR2 was clearly upregulated in diabetic tissue, as was seen in the darker bands (almost twice 
as dark as compared to control) for diabetc colon and jejunum ICC (Fig 7.). NCOR2 functions as 
a transcriptional repressor and its upregulation in diabetic conditions could be linked in the 
repression of transcription that is related to the downregulation of c-Kit in diabetic ICC (see 
Discussion for more details). However, immunoblotting analysis of BCL2L11 and NCOR2 
differed greatly in results. Under diabetic conditions, BCL2L11 was not detectable through 
Western blotting for both control and diabetic tissue samples, as concentrations were too low to 
be visible. 
Figure 7. NCOR2 is upregulated in diabetic jejunum and colon tissue as seen in the darker 
bands for diabetic jejunum and colon, while BCL2L11 was not detected. GAPDH was used 




Next-generation sequencing analysis of diabetic jejunum ICC, wild type jejunum ICC, 
diabetic colon ICC, and wild type colon ICC in the 120 total mice sample revealed that miR-10b-
5p had experienced the most change in expression levels. miR-10b-5p became the most reduced 
miRNA in diabetic conditions for both jejunum and colon ICC. This result is significant as miR-
10b is normally dominantly expressed in wild type jejunum and colon ICC. Diabetic conditions 
showed phenotypic change in ICC expression through its loss, along with the reduction of miR-
10b-5p. The downregulation of miR-10b coincides with the result of Agrawal et al. (2014), as 
they also saw the downregulation of miR-10b-5p under hypoxic conditions. According to Arden 
and Sivaprasad (2011) hypoxia is related to the emergence of diabetic conditions. This study also 
coincides with the results of Herrera et al. (2010) with the downregulation of miR-10b-5p in 
diabetic skeletal muscle, showing the contribution of miR-10b-5p in the pathophysiology of 
diabetic conditions. 
Gene analysis of miR-10b-5p yielded 2 potential targets which included Bcl2l11 and 
Ncor2. Bcl2l11 encodes Bim, a known apoptosis-inducing protein (Guerrero, Dong, Zhao, Lau-
Kilby, and Tarbell, 2014). BCL2L211 induces apoptosis when it binds to pro-survival proteins of 
the Bcl-2 family through the release of Bak or Bax proteins (Ewings, Wiggins, and Cook, 2007). 
However, our immunoblotting analysis showed that BCL2L11 was not detected under diabetic 
conditions as its concentrations were too low to be visible. This indicates that loss of ICCs 
through the downregulation of miR-10b may not be occurring because of an apoptotic pathway.  
NCOR2 on the other hand interestingly showed definite upregulation in diabetic tissue. 
This coincides with the observations of Mottis, Mouchiroud and Auwerx (2013) in NCOR2’s 
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regulatory functions, ranging from genomic stability, carcinogenesis, and metabolism such as 
seen in Type II diabetes. NCOR2 is a transcriptional coregulator that carries multiple 
independent repression domains (Chen and Evans, 1995). This corepressor aids in the 
recruitment of histone deacetylases to DNA promoters bound by interacting target transcription 
factors (Nagy, et al., 1997). Essentially, deacetylation takes out acetyl groups from histone tails, 
making them wrap and compress around the DNA. This interferes with the transcription of genes 
as it blocks access of transcription factors. Histone deacetylation results in a reduction of gene 
expression. 
Multiple studies have observed the interaction between NCOR2 and HDAC3 (Fischle et 
al., 2002; Yoon, Chan, Reynolds, Qin, and Wong, 2003). According to Perissi et al. (2010), 
HDAC3 seems to be the main enzyme that is responsible for the repressive activity of NCOR2 
with its stability and ability to reproduce with the protein.  
Other studies have also observed the interaction between NCOR2 and DNMT1 
suggesting that NCOR2 might employ some of its repressing activity through the modification of 
target expression by the methylation of DNMT1 (Sajedi et al., 2008). DNMT1 is an enzyme that 
regulates tissue-specific patterns of methylation in cytosine residues that also interacts with 
HDAC3 (Klein et al., 2011; Sarkar et al., 2011). 
From this, we proposed a new expected model that occurs in diabetic ICC with miR-10b-
5p. Essentially, with the downregulation of miR-10b-5p and upregulation of NCOR2, NCOR2 
recruits HDAC3 which leads to the methylation of DNMT1, resulting in the repression of 



























Figure 8. Proposed pathway of miR-10b-5p under normal and diabetic conditions along 
with the NCOR2 complex. Our expected model (A) states that under normal conditions in ICC, 
miR-10b-5p is upregulated along with c-Kit expression, while Ncor2 is downregulated. In 
diabetic conditions, miR-10b-5p is downregulated along with c-Kit expression, while Ncor2 is 
upregulated. In diabetic conditions (B), the NCOR2 complex shows that the upregulation of 
NCOR2 recruits HDAC3 which leads to the methylation of DNMT1, resulting in the repression 
of transcription that is related to the downregulation of c-Kit in ICC. However, no deaccetylation 




Further research that can be done on this topic is to test the proposed elements of the 
pathway in human tissue and observe if the relationships that were seen in this study still hold 
true to test the proposed elements of the pathway in human tissue and observe if the relationships 
that were seen in this study still hold true.  Also, more information is still needed in regards to 
the mechanisms of the NCOR2 complex. It is still unknown which transcription factor(s) help 
mediate the processes of the deacetylation and methylation that leads to the repression of 
transcription that is related to the downregulation of c-Kit in ICC. Finally, functional studies in 
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log range FPKM range
4.71-5 50,119.01-100,000
4.41-4.7 25,119.01-50,119
4.11-4.4 12,589.01-25,119
3.81-4.1 6,310.01-12,589
1.91-3.8 79.01-6,310
0.11-1.9 1.01-79
0-.1 0-1
